Kandel, M.; Bardet, A.; Dalle, S.; Allayous, C.; Mortier, L.; Guillot, B.; Dutriaux, C.; Leccia, M.-T.; Dalac, S.; Montaudie, H.;
et al. Cost-Effectiveness Analysis of Sequential Treatment Strategies for Advanced Melanoma in Real Life in France. Curr. Oncol. 2022, 29, 9255-9270.
https://doi.org/10.3390/curroncol29120725
AMA Style
Kandel M, Bardet A, Dalle S, Allayous C, Mortier L, Guillot B, Dutriaux C, Leccia M-T, Dalac S, Montaudie H,
et al. Cost-Effectiveness Analysis of Sequential Treatment Strategies for Advanced Melanoma in Real Life in France. Current Oncology. 2022; 29(12):9255-9270.
https://doi.org/10.3390/curroncol29120725
Chicago/Turabian Style
Kandel, Marguerite, Aurélie Bardet, Stéphane Dalle, Clara Allayous, Laurent Mortier, Bernard Guillot, Caroline Dutriaux, Marie-Thérèse Leccia, Sophie Dalac, Henri Montaudie,
and et al. 2022. "Cost-Effectiveness Analysis of Sequential Treatment Strategies for Advanced Melanoma in Real Life in France" Current Oncology 29, no. 12: 9255-9270.
https://doi.org/10.3390/curroncol29120725
APA Style
Kandel, M., Bardet, A., Dalle, S., Allayous, C., Mortier, L., Guillot, B., Dutriaux, C., Leccia, M.-T., Dalac, S., Montaudie, H., Saiag, P., Legoupil, D., Brunet-Possenti, F., Arnault, J.-P., Quatrebarbes, J. D., Beylot-Barry, M., Maubec, E., Lesimple, T., Aubin, F.,
... Borget, I.
(2022). Cost-Effectiveness Analysis of Sequential Treatment Strategies for Advanced Melanoma in Real Life in France. Current Oncology, 29(12), 9255-9270.
https://doi.org/10.3390/curroncol29120725
